# Paclitaxel

## FORMOXOL inj 60mg/10mL

| TAH Drug Code      | [IFOR10](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IFOR10)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Advanced ovarian cancer， breast cancer with axillary lymph node metastasis， as part of adjuvant chemotherapy following treatment with doxorubicin (including the use of Doxorubicin)， for metastatic breast cancer， non-small cell lung cancer， and second-line therapy for AIDS-related Kaposi's sarcoma (unless contraindicated， should at least include anthracycline chemotherapy agents). Used in combination with CISPLATIN as first-line therapy for advanced ovarian cancer. Used in combination with GEMCITABINE for patients with locally recurrent breast cancer that has been treated with anthracyclines and is not surgically resectable or for metastatic breast cancer， and in combination with Herceptin for the treatment of patients with HER-2 overexpressing metastatic breast cancer who have not received prior chemotherapy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Dosing             | Premedication with dexamethasone 20 mg orally at 12 and 6 hours prior to paclitaxel， promethazine 25 or 50 mg or diphenhydromine 50 mg IV 30-60 minutes prior to paclitaxel， and cimetidine 300 mg， ranitidine 50 mg or famotidine 20 mg IV 30-60 minutes prior to paclitaxel is recommended.Baseline neutrophil count should be ?1，500 cells/mm3 (1.5 x 10^9 cells/L)， platelets should be ?100，000 cells/mm3 (100 x 10^9 cells/L) prior to treatment. [Ovarian Caner， advanced]- Previously untreated: 175 mg/m2 infused over 3 hours every 3 weeks in combination with cisplatin 75 mg/m2 or 135 mg/m2 over 24 hours administered every 3 weeks in combination with cisplatin 75 mg/m2.- Previously treated: 135 or 175 mg/m2 infused over 3 hours every 3 weeks.  [Breast Cancer]- Adjuvant treatment: 175 mg/m2 infused over 3 hours every 3 weeks for 4 cycles (administer sequentially following an anthracycline-containing regimen).- Breast cancer， metastatic or relapsed: 175 mg/m2 infused over 3 hours every 3 weeks. [Non-small cell lung cancer (NSCLC)] 135 mg/m2 infused over 24 hours every 3 weeks in combination with cisplatin 75 mg/m2. [Kaposi sarcoma， AIDS related] 135 mg/m2 over 3 hours every 3 weeks or 100 mg/m2 over 3 hours every 2 weeks (due to dose-related toxicity， the 100 mg/m2 dose should be used for patients with a lower performance status). |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Contraindications  | Hypersensitivity to paclitaxel， polyoxyl 35/polyoxyethylated castor oil (Cremophor EL)， or any component of the formulation; treatment of solid tumors in patients with baseline neutrophil counts <1，500/mm3; treatment of Kaposi sarcoma in patients with baseline neutrophil counts <1，000/mm3.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Adverse Effects    | Bone marrow suppression， peripheral neuropathy， GI disturbances， alopecia， hypersensitivity. Dermatologic: Alopecia (55% to 96% ) Gastrointestinal: Diarrhea (16% to 90% )， Inflammatory disease of mucous membrane (5% to 45% )， Nausea and vomiting， Any grade (9% to 88% ) Hematologic: Anemia， Any grade (47% to 96% )， Leukopenia (90% )， Neutropenia， Any grade (78% to 100% )， Thrombocytopenia， Any grade (4% to 68% ) Immunologic: Immune hypersensitivity reaction， Any grade (2% to 45% ) Musculoskeletal: Arthralgia， Myalgia Neurologic: Peripheral neuropathy， Any grade (42% to 79% )                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| More Info          | [UpToDate](https://www.uptodate.com/contents/paclitaxel-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |

## Formoxol inj 30mg/5mL

| TAH Drug Code      | [IFORM](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IFORM)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Advanced ovarian cancer， breast cancer with axillary lymph node metastasis， as part of adjuvant chemotherapy following treatment with doxorubicin (including the use of Doxorubicin)， for metastatic breast cancer， non-small cell lung cancer， and second-line therapy for AIDS-related Kaposi's sarcoma (unless contraindicated， should at least include anthracycline chemotherapy agents). Used in combination with CISPLATIN as first-line therapy for advanced ovarian cancer. Used in combination with GEMCITABINE for patients with locally recurrent breast cancer that has been treated with anthracyclines and is not surgically resectable or for metastatic breast cancer， and in combination with Herceptin for the treatment of patients with HER-2 overexpressing metastatic breast cancer who have not received prior chemotherapy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Dosing             | Premedication with dexamethasone 20 mg orally at 12 and 6 hours prior to paclitaxel， promethazine 25 or 50 mg or diphenhydromine 50 mg IV 30-60 minutes prior to paclitaxel， and cimetidine 300 mg， ranitidine 50 mg or famotidine 20 mg IV 30-60 minutes prior to paclitaxel is recommended.Baseline neutrophil count should be ?1，500 cells/mm3 (1.5 x 10^9 cells/L)， platelets should be ?100，000 cells/mm3 (100 x 10^9 cells/L) prior to treatment. [Ovarian Caner， advanced]- Previously untreated: 175 mg/m2 infused over 3 hours every 3 weeks in combination with cisplatin 75 mg/m2 or 135 mg/m2 over 24 hours administered every 3 weeks in combination with cisplatin 75 mg/m2.- Previously treated: 135 or 175 mg/m2 infused over 3 hours every 3 weeks.  [Breast Cancer]- Adjuvant treatment: 175 mg/m2 infused over 3 hours every 3 weeks for 4 cycles (administer sequentially following an anthracycline-containing regimen).- Breast cancer， metastatic or relapsed: 175 mg/m2 infused over 3 hours every 3 weeks. [Non-small cell lung cancer (NSCLC)] 135 mg/m2 infused over 24 hours every 3 weeks in combination with cisplatin 75 mg/m2. [Kaposi sarcoma， AIDS related] 135 mg/m2 over 3 hours every 3 weeks or 100 mg/m2 over 3 hours every 2 weeks (due to dose-related toxicity， the 100 mg/m2 dose should be used for patients with a lower performance status). |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Contraindications  | Hypersensitivity to paclitaxel， polyoxyl 35/polyoxyethylated castor oil (Cremophor EL)， or any component of the formulation; treatment of solid tumors in patients with baseline neutrophil counts <1，500/mm3; treatment of Kaposi sarcoma in patients with baseline neutrophil counts <1，000/mm3.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Adverse Effects    | Bone marrow suppression， peripheral neuropathy， GI disturbances， alopecia， hypersensitivity. Dermatologic: Alopecia (55% to 96% ) Gastrointestinal: Diarrhea (16% to 90% )， Inflammatory disease of mucous membrane (5% to 45% )， Nausea and vomiting， Any grade (9% to 88% ) Hematologic: Anemia， Any grade (47% to 96% )， Leukopenia (90% )， Neutropenia， Any grade (78% to 100% )， Thrombocytopenia， Any grade (4% to 68% ) Immunologic: Immune hypersensitivity reaction， Any grade (2% to 45% ) Musculoskeletal: Arthralgia， Myalgia Neurologic: Peripheral neuropathy， Any grade (42% to 79% )                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| More Info          | [UpToDate](https://www.uptodate.com/contents/paclitaxel-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |

